Winter Springs, Fla. (December 14, 2021) – The push to find effective ways to treat cancer is not quick or easy. But after working on expanding the use of tumor-treating fields for several years, the efforts of Winter Springs-based LifeBridge 10000 have now gained the attention of a national publication.

This month, LifeBridge 10000 is featured as one of the top 10 emerging medical technology companies in the world as the magazine’s cover story. The company is the only one listed in Florida.

“This type of recognition is truly priceless for a growing small business, particularly one working with cutting-edge research, and our team is so proud of Peter and his team at LifeBridge 10000,” says Carol Ann Logue, director, programs & operations, UCF Business Incubation Program. “They have been working with us for a few years and it’s well deserved to have his technology be featured in such a fashion.”

LifeBridge 10000 is developing a next generation of technology to work with tumor-treating fields designed specifically for the late-stage cancer patient with disease in multiple locations, such as the lung and liver simultaneously.

Because of the limited scope of the present form of tumor-treating fields, Travers’ company developed a new form of the therapy for patients fighting wide-spread disease.

“We were very surprised to see our company featured on the front cover of Medtech Outlook,” says Peter Travers, CEO & founder of LifeBridge 10000. “We’ve been working very hard to bring this technology to market to help thousands upon thousands of people with multiple tumors and its exciting to receive such a recognition.”

To read the December issue of Medtech Outlook and see the full profile, click here.

#  #  #

For more information media should contact –

Peter Travers, LifeBridge 10000, 407-416-1099,

Rafael Caamano, UCF Business Incubation Program, 407-408-4297 ,

Alan Byrd, Alan Byrd & Associates, 407-415-8470,

About LifeBridge 10000: LifeBridge 10000 LLC was founded in January of 2015 by a marketing professional, a private investor, and two senior engineers. The company is headquartered in Longwood, FL and has been accepted into the University of Central Florida Business Incubation program, in Winter Springs, as a full participant.

The managing member, Mr. Travers, and his late wife, Laurie, were immersed in the culture of cancer for almost 18 years, which led to the work with TTF (Tumor Treating Fields) technology. Laurie’s Breast Cancer was discovered as stage 3, progressing to stage 4 within the first year. She experienced 12 reoccurrences, 9 rounds of chemotherapy, four series of radiation treatments, thoracentesis to remove fluid from the pleura around her lung 9 times, and participation in two clinical trials.    Treatment with TTF extended Laurie’s life an additional 3 years. Improvement and stability only occurred where Laurie used TTF.

LifeBridge 10000 was founded because of this experience. The objective of the Company is to extend and improve the quality of life for patients with advanced stage cancer by providing a 4th treatment option with their TTF System called the LB10000.  The LifeBridge LB10000 offers the hope of extended survival, improved quality of life, and freedom from the toxic side effects of chemotherapy or radiation. Patients with late stage cancer often do not survive long enough to try new breakthrough treatments. For more information, visit

About the UCF Business Incubation Program: The University of Central Florida Business Incubation Program is a community resource that provides early-stage companies with the tools, training and infrastructure to become financially stable, high growth/impact enterprises. Since 1999, this award-winning program has provided vital business development resources resulting in over 300 local startup companies reaching their potential faster and graduating into the community where they continue to grow and positively impact the local economy.

With seven facilities throughout the region, the UCF Business Incubation Program is an economic development partnership between the University of Central Florida, the Corridor, Orange, Osceola, Seminole and Volusia Counties, and the cities of Kissimmee, Orlando and Winter Springs. For the 2017/2018 fiscal years, the activities of these participating firms have helped to sustain more than 6,725 local jobs and have had a cumulative impact of over $725 million on regional GDP and over $1.3 billion on regional sales. During the same period, the program has returned more than $12.00 in state and local taxes for every $1.00 invested in the program. In addition, for every $1.00 of public investment the firms also produced $118 of additional regional GDP and $226 of regional sales. For more information, visit